Mangiferin attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting TLR4/p65 and TGF-β1/Smad2/3 pathway.
Li JiaPing SunHui GaoJie ShenYuan GaoCheng MengShidong FuHuijuan YaoGong ZhangPublished in: The Journal of pharmacy and pharmacology (2019)
Mangiferin attenuates BLM-induced pulmonary fibrosis in mice through inhibiting TLR4/p65 and TGF-β1/Smad2/3 pathway.